News and Articles on Ayurveda, Yoga, Kundalini and other Indian way of health and medicines.
The Indian drug regulator’s subject expert committee has recommended approving Zydus Cadila’s three-dose COVID-19 vaccine -ZyCoV-D- for emergency use authorization (EUA), Reuters reported citing CNBC-TV18.
India is likely to have an indigenous Covid-19 vaccine for children by September, Indian Council of Medical Research (ICMR)’s National Institute of Virology (Pune) director Priya Abraham has said amid the ongoing phase II and III trials of Covaxin for the 2-18 age group.
Equipped with the pressure swing adsorption (PSA) technique, the technology has been transferred and licensed to a Bengaluru-based company Albot Technologies Private Limited. The oxygen concentrator works at a flow rate of 10 litres per minute (LPM) with an oxygen purity of 92% ±3. The concentrator has an adjustable capacity of 1 to 10 LPM which can be used for both medical as well as personal uses.
In a move that will boost the production capacity of indigenously developed Covid-19 vaccine Covaxin, Indian Immunologicals Ltd (IIL) on Friday handed over the first batch of Covaxin drug substance produced at its Karakapatla facility in Genome Valley to Bharat Biotech.
Bharat Biotech’s intranasal vaccine is the first nasal vaccine that has received the regulatory approval for Phase 2 trials. This is the first of its kind COVID-19 jab to undergo human clinical trials in India. BBV154 is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine. BBIL has in-licensed technology from Washington University in St Louis, USA.
iSERA Biological said the company might able to deliver the drug at a tenth of the cost charged by the alternative antibody cocktail developed by pharma major Roche by the end of this year
People who received the jab against the coronavirus disease (Covid-19) outside the country will soon be able to download their vaccination certificate through the CoWin, a portal introduced by the Indian government to streamline the inoculation drive process, Livemint reported on Tuesday, quoting a government official.
NPPA monitors the ceiling price of the scheduled formulations to ensure that the MRP of such formulations are within the range of ceiling price and monitors non-scheduled formulations to ensure that their MRP does not increase by more than 10% during the preceding twelve months.
The National Telemedicine Service of the Ministry of Health & Family Welfare has completed 90 lakh teleconsultations in the country. The last 10 lakh consultations came up in record 17 days.
In a landmark initiative to ensure safety from COVID-19, Ministry of Health and Family Welfare has taken a decision to allow foreign nationals residing in India to get registered on CoWin portal to take COVID-19 vaccine. They can use their passport as identity document for the purpose of registration on CoWIN portal. Once they are registered on this portal, they will get a slot for vaccination.
